Literature DB >> 11046211

Low- and medium-molecular-weight hydroxyethyl starches: comparison of their effect on blood coagulation.

M Jamnicki1, T Bombeli, B Seifert, A Zollinger, V Camenzind, T Pasch, D R Spahn.   

Abstract

BACKGROUND: High-molecular-weight hydroxyethyl starch (HES) compromises blood coagulation more than medium-molecular-weight HES. The authors compared medium molecular weight HES (200 kd [HES200]) and low-molecular-weight HES (70 kd [HES70]).
METHODS: In a prospective, double-blind, randomized-sequence crossover study, 22 male volunteers received 15 ml/kg HES200 and HES70. Blood samples were taken before and 5 min, 30 min, 1 h, 2 h, 4 h, 8 h, and 24 h after infusion. The following parameters were analyzed at all time points: prothrombin time, activated partial thromboplastin time, fibrinogen, factor VIII, antigenetic and functional von Willebrand factor, platelets, Thrombelastograph analysis parameters (reaction time, coagulation time, maximum amplitude, angle alpha, and clot lysis 30 and 60 min after maximum amplitude), ionized calcium, hematocrit, HES plasma concentration, molecular weight (weight average and number average), molar substitution, and polydispersity (weight average/number average). Repeated-measures analysis of variance (P < 0.05) was used to compare the response of the aforementioned parameters to the infusion of HES70 and HES200.
RESULTS: Both HES solutions had a significant impact on all parameters. A slightly greater compromise with HES200 was found in activated partial thromboplastin time (P = 0.010), factor VIII (P = 0.009), antigenetic von Willebrand factor (P = 0.041), functional von Willebrand factor (P = 0.026), maximum amplitude (P = 0.008), and angle alpha (P = 0.003). No difference was established with the other parameters. HES concentration (P < 0.001), weight average (P < 0.001), number average (P < 0.001), and polydispersity (P < 0.001) were higher with HES200. There was no difference with molar substitution (P = 0.091).
CONCLUSIONS: Low-molecular-weight hydroxyethyl starch (70 kd) compromises blood coagulation slightly less than HES200, but it is unclear whether this is clinically relevant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11046211     DOI: 10.1097/00000542-200011000-00016

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  11 in total

1.  Intraoperative hydroxyethyl starch 70/0.5 administration may increase postoperative bleeding: a retrospective cohort study.

Authors:  Toko Fukushima; Shigehiko Uchino; Tomoko Fujii; Masanori Takinami; Shoichi Uezono
Journal:  J Anesth       Date:  2017-03-24       Impact factor: 2.078

2.  A calcium-containing electrolyte-balanced hydroxyethyl starch (HES) solution is associated with higher factor VIII activity than is a non-balanced HES solution, but does not affect von Willebrand factor function or thromboelastometric measurements--results of a model of in vitro haemodilution.

Authors:  Juliane Rau; Christoph Rosenthal; Elisabeth Langer; Michael Sander; Erika Schulte; Michael Schuster; Christian von Heymann
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

3.  Before-after study of a restricted fluid infusion strategy for management of donor hepatectomy for living-donor liver transplantation.

Authors:  Yoshihito Fujita; Akinori Takeuchi; Takeshi Sugiura; Tomonori Hattori; Nobuko Sasano; Yuichiro Mizuochi; Kazuya Sobue
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

4.  Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4.

Authors:  Ornella Piazza; Giuliana Scarpati; Rosalba Tufano
Journal:  Int J Gen Med       Date:  2010-10-05

5.  A Comparative Coagulopathic Study for Treatment of Vasospasm by Using Low- and High-molecular Weight Hydroxyethyl Starches.

Authors:  Sung Ho Hwang; Yu Sam Won; Jang Sun Yu; Jae Young Yang; Chun Sik Choi
Journal:  J Korean Neurosurg Soc       Date:  2007-11-20

6.  The effects of blood pressure on rebleeding when using ExcelArrest™ in a porcine model of lethal femoral injury.

Authors:  Hayong Hirst; John Brinkman; Amy Beasley; Richard Crocker; Joseph O'Sullivan
Journal:  J Emerg Trauma Shock       Date:  2011-04

Review 7.  Effects of hemoglobin-based oxygen carriers on blood coagulation.

Authors:  Kimia Roghani; Randall J Holtby; Jonathan S Jahr
Journal:  J Funct Biomater       Date:  2014-12-12

8.  Effect of synthetic colloid administration on coagulation in healthy dogs and dogs with systemic inflammation.

Authors:  V Gauthier; M K Holowaychuk; C L Kerr; A M E Bersenas; R Darren Wood
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

Review 9.  Intravenous Fluid Administration and the Coagulation System.

Authors:  Corrin J Boyd; Benjamin M Brainard; Lisa Smart
Journal:  Front Vet Sci       Date:  2021-04-15

10.  Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven).

Authors:  D Viuff; B Lauritzen; A E Pusateri; S Andersen; R Rojkjaer; P I Johansson
Journal:  Br J Anaesth       Date:  2008-06-18       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.